Definitive Healthcare Corp.

NASDAQ:DH

Medical - Healthcare Information Services

Healthcare
$1.34 +1.85%

+$0.01 today

Market cap
$143.60M
Beta
1.33
P/E (TTM)
-0.5
EPS (TTM)
-$1.63
52W Low $0.77High $4.70

Volume 0.43M

Average 0.32M

DH Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Definitive Healthcare Corp.NASDAQ: DH

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 59.6%

Gross margin was 59.6% in Q1 FY2026, down 14.3 pp from a year earlier. On a trailing-twelve-month basis it was 72.5%, down 4.4 pp year over year. Over 3 fiscal years it narrowed by 5.0 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
59.6%-8.5 pp QoQ
Last fiscal yearDec 2025
75.9%-2.4 pp YoY
LTMMar 2026
72.5%-4.4 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-14.3 pp——
1 year-2.4 pp——
3 years-5.0 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
75.9%
Year-over-year change
-2.4pp

Gross Margin vs competitors

How DH compares with its peers on the latest reported figures

  • DH's LTM Mar 2026 gross margin of 72.5% is the 2nd highest of the 8 companies compared; the peer median is 55.9%.
  • Its year-over-year change of -4.4 pp is the 7th highest of 8, against a peer median of -0.8 pp.
  • Over three fiscal years its change of -5.0 pp compares with a peer median of -3.8 pp.
DH Competitors Peer median
Gross Margin for DH and competitors
Company Period LTM level YoY 3-year change
SPOKSpok Holdings, Inc.LTM Mar 202687.1% +22.8 pp+22.9 pp
DHDefinitive Healthcare Corp.LTM Mar 202672.5% -4.4 pp-5.0 pp
SOPHSOPHiA GENETICS S.A.LTM Mar 202667.3% -0.8 pp-3.8 pp
SLPSimulations Plus, Inc.LTM Feb 202662.0% +6.7 pp-21.5 pp
NRCNational Research CorporationLTM Mar 202655.9% -3.3 pp-6.0 pp
TBRGTruBridge, Inc.LTM Mar 202651.2% -0.9 pp+4.0 pp
EDITEditas Medicine, Inc.LTM Mar 20265.8% +124.1 pp+32.1 pp
NAKANakamoto Inc.LTM Mar 2026-376.0% -309.7 pp-604.8 pp
KYTXKyverna Therapeutics, Inc.FY2025— ——
CABACabaletta Bio, Inc.FY2025— ——
Peer median (excluding DH) 55.9%-0.8 pp-3.8 pp

Competitors are the stored peer set for DH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue166.15M222.65M251.42M252.2M241.52M
Cost of Revenue40.69M42.63M47.48M54.73M58.25M
Gross Profit125.47M180.03M203.93M197.47M183.28M
Gross Margin75.5%80.9%81.1%78.3%75.9%
Research & Development18.57M34.89M42.44M36.52M34.78M
Selling, General & Admin89.25M141.15M153.4M133.07M133.26M
Operating Expenses152.78M224.07M533.73M908.29M203.86M
Depreciation & Amortization59.95M56.9M51.75M51.67M35.82M
EBITDA23.08M26.23M(241.23M)(567.24M)(162.15M)
EBITDA Margin13.9%11.8%-95.9%-224.9%-67.1%
Operating Income(27.32M)(44.04M)(329.8M)(710.82M)(20.58M)
Operating Margin-16.4%-19.8%-131.2%-281.8%-8.5%
Interest Income29K2.79M13.64M14.59M6.95M
Interest Expense25.9M11.2M15.2M14.84M11.29M
Other Income / Expenses(35.45M)2.17M21.62M77.08M(188.67M)
Income Before Tax(62.77M)(41.88M)(308.18M)(633.75M)(209.26M)
Pre-Tax Margin-37.8%-18.8%-122.6%-251.3%-86.6%
Income Tax Expense(443K)(17.7M)(18.55M)(42.3M)(9.96M)
Net Income(51.91M)(7.22M)(202.39M)(413.12M)(138.93M)
Net Margin-31.2%-3.2%-80.5%-163.8%-57.5%
EPS (Basic)(0.19)(0.07)(1.79)(3.54)(1.30)
EPS (Diluted)(0.19)(0.07)(1.79)(3.54)(1.30)
Weighted Avg Shares97.03M101.11M112.76M116.64M106.65M
Weighted Avg Shares (Diluted)97.03M101.11M112.76M116.64M106.65M

Definitive Healthcare Corp.

NASDAQ:DH

Intrinsic Alpha fair value

Locked

Current Price

$1.34

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.